MMP9 and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, XN regulates the anti-angiogenic effects of NF-κB by suppressing the level of MMP-9, VEGF, and ICAM-1 stimulated by TNF in chronic myelogenous leukemia [115].